Related references
Note: Only part of the references are listed.Hematopoiesis: A Human Perspective
Sergei Doulatov et al.
CELL STEM CELL (2012)
The vascular niche: home for normal and malignant hematopoietic stem cells
P. L. Doan et al.
LEUKEMIA (2012)
Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies
Angelica Trujillo et al.
JOURNAL OF ONCOLOGY (2012)
Differential survival of AML subpopulations in NOD/SCID mice
Mario Schubert et al.
EXPERIMENTAL HEMATOLOGY (2011)
Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2R gamma c-deficient mice
Jean-Emmanuel Sarry et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
Marina Y. Konopleva et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome
Patries M. Herst et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation
A. Gandillet et al.
LEUKEMIA (2011)
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
George Deeb et al.
LEUKEMIA RESEARCH (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells
Faiyaz Notta et al.
NATURE (2011)
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert et al.
NATURE MEDICINE (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
Max Jan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Irene Ma et al.
STEM CELL REVIEWS AND REPORTS (2011)
Control of hematopoietic stem cells by the bone marrow stromal niche: the role of reticular cells
Takashi Nagasawa et al.
TRENDS IN IMMUNOLOGY (2011)
Leukemia regression by vascular disruption and antiangiogenic therapy
Gerard J. Madlambayan et al.
BLOOD (2010)
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
David C. Taussig et al.
BLOOD (2010)
Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche
Ahmed Mohyeldin et al.
CELL STEM CELL (2010)
Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells
Chantal Cerdan et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells
Thomas Walenda et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
Malcolm R. Alison et al.
JOURNAL OF PATHOLOGY (2010)
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
Ting Li et al.
LABORATORY INVESTIGATION (2010)
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Yingzi Wang et al.
SCIENCE (2010)
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
Pablo Ramirez et al.
BLOOD (2009)
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
Emina H. Huang et al.
CANCER RESEARCH (2009)
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Siddhartha Jaiswal et al.
CELL (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Liqing Jin et al.
CELL STEM CELL (2009)
Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes
Dan Ran et al.
EXPERIMENTAL HEMATOLOGY (2009)
Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias
Ying Yan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44
Wolfgang Wagner et al.
CELLS TISSUES ORGANS (2008)
Aging of hematopoietic stem cells is regulated by the stem cell niche
Wolfgang Wagner et al.
EXPERIMENTAL GERONTOLOGY (2008)
Identification of a Small Subpopulation of Candidate Leukemia-Initiating Cells in the Side Population of Patients with Acute Myeloid Leukemia
Bijan Moshaver et al.
STEM CELLS (2008)
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
Fumihiko Ishikawa et al.
NATURE BIOTECHNOLOGY (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Hox genes in hematopoiesis and leukemogenesis
B. Argiropoulos et al.
ONCOGENE (2007)
The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells
Daniel J. Pearce et al.
EXPERIMENTAL HEMATOLOGY (2007)
Aberrant marker expression patterns on the CD34+CD38-stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission
A. van Rhenen et al.
LEUKEMIA (2007)
Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential
A. M. S. Cheung et al.
LEUKEMIA (2007)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis
Claudia Scholl et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction
Wolfgang Wagner et al.
EXPERIMENTAL HEMATOLOGY (2007)
CXCR4 is a prognostic marker in acute myelogenous leukemia
Anke C. Spoo et al.
BLOOD (2007)
Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity
L. Zahiragic et al.
LEUKEMIA (2007)
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
Emma Kulimova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity
Stefania Corti et al.
STEM CELLS (2006)
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML
DJ Pearce et al.
BLOOD (2006)
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival
A van Rhenen et al.
CLINICAL CANCER RESEARCH (2005)
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples
DJ Pearce et al.
STEM CELLS (2005)
Antiangiogenic therapy in acute myelogenous leukemia: Targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies
KJ Hatfield et al.
CURRENT CANCER DRUG TARGETS (2005)
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow
A Avigdor et al.
BLOOD (2004)
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The hemangioblast: Cradle to clinic
CR Cogle et al.
EXPERIMENTAL HEMATOLOGY (2004)
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity
DA Hess et al.
BLOOD (2004)
The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells
Z Gadhoum et al.
LEUKEMIA & LYMPHOMA (2004)
ABCG2 -: a transporter for all seasons
B Sarkadi et al.
FEBS LETTERS (2004)
Membrane properties of rat embryonic multipotent neural stem cells
JL Cai et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells
AS Bailey et al.
BLOOD (2004)
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias:: Therapy with sequential 1-β-D-arabinofuranosylcytosine, mitoxantrone, and bevacizumab
JE Karp et al.
CLINICAL CANCER RESEARCH (2004)
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF
S Wellmann et al.
LEUKEMIA (2004)
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
A Cozzio et al.
GENES & DEVELOPMENT (2003)
Osteoblastic cells regulate the haematopoietic stem cell niche
LM Calvi et al.
NATURE (2003)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)
YH Guan et al.
BLOOD (2003)
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
ML Guzman et al.
BLOOD (2001)
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
GG Wulf et al.
BLOOD (2001)
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells
CT Jordan et al.
LEUKEMIA (2000)
Share Paper
